.BROSSARD, QUÉBEC, CANADA--(Marketwire - Sept. 13, 2011) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announced today, as mentioned in a press release from Creso Exploration Inc. ("CRESO") dated September 9, 2011, surface sampling results on CRESO's Gibson property located in the West Shining Tree district of Northeastern Ontario.

Sampling at Gibson was carried-out principally to test CARDS (Computer Aided Resource Detection System) anomalies that were developed on contract by DIAGNOS.

Working in tandem with CRESO personnel, DIAGNOS geologists sampled quartz veins in shear zones at the Gibson property from 112 locations, six of which returned assays above 1 g/t Au, including higher grade assays up to 20.1 g/t Au, 10.7 g/t Au, and 7.16 g/t Au.

DIAGNOS was mandated by CRESO to conduct exploration on the identified targets using our proprietary CARDS system. Further exploration work is expected to follow the extension of this new mineralized zone.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

About CRESO

The Corporation's principal mining exploration holdings are located in the Shining Tree mining camp of Northern Ontario within 100 km of the Timmins and Kirkland Lake mining camps, and additional interests are held in base metal properties in Guatemala.

Forward-looking information

This document contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.